EQL Pharma AB (EQL)

Currency in SEK
60.5000
0.0000(0.00%)
Closed·
EQL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
59.000060.5000
52 wk Range
58.200098.6000
Key Statistics
Prev. Close
57
Open
60.3
Day's Range
59-60.5
52 wk Range
58.2-98.6
Volume
28.76K
Average Volume (3m)
47.93K
1-Year Change
-4.57%
Book Value / Share
7.94
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
EQL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

EQL Pharma AB News & Analysis

Show more

EQL Pharma AB Company Profile

EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers injection products for inpatient care and formulations for outpatient care. EQL Pharma AB (publ) was incorporated in 2006 and is based in Lund, Sweden.

EQL Pharma AB Earnings Call Summary for Q1/2026

  • Revenue surged 30% YoY to SEK 107M, beating forecasts; EPS slightly missed at 0.44 vs 0.45 expected
  • Stock rose 2.22% post-earnings; company maintains 30% full-year growth target and aims for 25% EBITDA margin
  • Expansion into Germany and Netherlands underway; Special Generics unit launched with products expected by 2026
  • CEO emphasized European rollout and business investment; company aims to reduce leverage from 3.7x to 2.5x EBITDA
  • Medilink acquisition integration on track; cautious optimism expressed regarding future M&A opportunities
Last Updated: 08/08/2025, 13:22
Read Full Transcript

Compare EQL to Peers and Sector

Metrics to compare
EQL
Peers
Sector
Relationship
P/E Ratio
42.0x10.6x−0.7x
PEG Ratio
0.710.010.00
Price/Book
7.7x0.9x2.6x
Price / LTM Sales
4.5x0.4x3.3x
Upside (Analyst Target)
48.8%69.8%39.6%
Fair Value Upside
Unlock23.7%6.0%Unlock

Earnings

Latest Release
Aug 19, 2025
EPS / Forecast
0.34 / --
Revenue / Forecast
107.20M / 114.20M
EPS Revisions
Last 90 days

EQL Income Statement

People Also Watch

298.80
ADDTb
-0.53%
35.5
NIBEb
-2.20%
720.80
EVOG
-0.66%
372.20
YAR
-0.80%
413.00
BOL
-1.34%

FAQ

What Stock Exchange Does EQL Pharma Trade On?

EQL Pharma is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for EQL Pharma?

The stock symbol for EQL Pharma is "EQL."

What Is the EQL Pharma Market Cap?

As of today, EQL Pharma market cap is 1.79B.

What Is EQL Pharma's Earnings Per Share (TTM)?

The EQL Pharma EPS (TTM) is 1.41.

When Is the Next EQL Pharma Earnings Date?

EQL Pharma will release its next earnings report on 06 Nov 2025.

From a Technical Analysis Perspective, Is EQL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has EQL Pharma Stock Split?

EQL Pharma has split 0 times.

How Many Employees Does EQL Pharma Have?

EQL Pharma has 20 employees.

What is the current trading status of EQL Pharma (EQL)?

As of 15 Oct 2025, EQL Pharma (EQL) is trading at a price of 60.5000, with a previous close of 57.00. The stock has fluctuated within a day range of 59.0000 to 60.5000, while its 52-week range spans from 58.2000 to 98.6000.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.